JAK3 and posterior cortical atrophy: In addition, we predicted six potential compounds, including purvalanol-A, aminopurvalanol-A, JAK3-inhibitor-VI, PHA-793887, Floxuridine, and Teniposide, for the treatment of PCa using the cMap Database.